Literature DB >> 20629617

Thymic carcinoma: current and future therapeutic interventions.

Glen J Weiss1.   

Abstract

IMPORTANCE OF THE FIELD: Since first reported just over 30 years ago, some progress has been made in our understanding of thymic cancer - an extremely rare cancer - and how to treat it. However, we are far from the ultimate goal of cure for most patients. AREAS COVERED IN THIS REVIEW: This review provides an overview of the thymic gland's development; features of thymic carcinoma, including its molecular characterization, current staging, and treatment guidelines; and progress made to date for treating advanced disease, concluding with future directions and prospects. WHAT THE READER WILL GAIN: As scientists apply new molecular tools to learn more about cancer, we find that even among common cancers, there exist heterogeneous subtypes necessitating different treatment paradigms. Thus, a one-size-fits-all approach to cancer treatment is being displaced with precision medicine to target the 'Achilles heel' of thymic tumors. TAKE HOME MESSAGE: When approaching thymic carcinoma, we must identify the key driving forces to target its context(s) of vulnerability to ensure the greatest impact of treatment for patients with this extremely rare cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629617     DOI: 10.1517/13543784.2010.504708

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  4 in total

1.  Expression of excision repair cross-complementation group 1 and class III β-tubulin in thymic carcinoma.

Authors:  Katsuhiro Okuda; Risa Oda; Ayumi Suzuki; Tsutomu Tatematsu; Hiroshi Haneda; Satoru Moriyama; Motoki Yano; Ryoichi Nakanishi
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

Review 2.  Thymic Carcinoma: A Review.

Authors:  Doaa Alqaidy; Cesar A Moran
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

3.  nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma.

Authors:  Go Makimoto; Keiichi Fujiwara; Hiromi Watanabe; Nobuhisa Kameyama; Mizuho Matsushita; Kammei Rai; Ken Sato; Toshiro Yonei; Toshio Sato; Takuo Shibayama
Journal:  Case Rep Oncol       Date:  2014-01-11

4.  Thymic carcinoma metastasize to the small intestine: a case report.

Authors:  Yi Yuan; Hong Pu; Ming-Hui Pang; Yi-Sha Liu; Hang Li
Journal:  BMC Gastroenterol       Date:  2020-10-28       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.